Journey Medical secures third major GPO contract for Emrosi rosacea drug
Go back to Journey Medical secures third major GPO contract for Emrosi rosacea drug| (NASDAQ: DERM) | Delayed: 6.83 +0.15 (2.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.68 | 52 Week High | $36.34 | |||
| Open | $6.75 | 52 Week Low | $17.42 | |||
| Day High | $6.94 | P/E | N/A | |||
| Day Low | $6.75 | EPS | $0.00 | |||
| Volume | 36,605 | |||||
| Fabien Corp (NASDAQ: FBIO) | Delayed: 3.21 +0.21 (7.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.00 | 52 Week High | $4.66 | |||
| Open | $3.04 | 52 Week Low | $2.01 | |||
| Day High | $3.25 | P/E | N/A | |||
| Day Low | $3.02 | EPS | $0.00 | |||
| Volume | 703,203 | |||||
